Keith A. Goldan - Net Worth and Insider Trading
Keith A. Goldan Net Worth
The estimated net worth of Keith A. Goldan is at least $718,234 dollars as of 2024-12-26. Keith A. Goldan is the CFO of Syndax Pharmaceuticals Inc and owns about 52,623 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $680,152. Keith A. Goldan is the CFO of OptiNose Inc and owns about 90,193 shares of OptiNose Inc (OPTN) stock worth over $37,683. Keith A. Goldan is also the SVP and CFO of Fibrocell Science Inc and owns about 133 shares of Fibrocell Science Inc (FCSC) stock worth over $399. Details can be seen in Keith A. Goldan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith A. Goldan has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith A. Goldan
Keith A. Goldan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith A. Goldan owns 3 companies in total, including OptiNose Inc (OPTN) , Fibrocell Science Inc (FCSC) , and Syndax Pharmaceuticals Inc (SNDX) .
Click here to see the complete history of Keith A. Goldan’s form 4 insider trades.
Insider Ownership Summary of Keith A. Goldan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OPTN | OptiNose Inc | 2021-09-16 | Chief Financial Officer |
| FCSC | Fibrocell Science Inc | 2016-03-01 | SVP and CFO |
| SNDX | Syndax Pharmaceuticals Inc | 2024-06-14 | Chief Financial Officer |
Keith A. Goldan Latest Holdings Summary
Keith A. Goldan currently owns a total of 3 stocks. Among these stocks, Keith A. Goldan owns 52,623 shares of Syndax Pharmaceuticals Inc (SNDX) as of June 14, 2024, with a value of $680,152 and a weighting of 94.7%. Keith A. Goldan owns 90,193 shares of OptiNose Inc (OPTN) as of September 16, 2021, with a value of $37,683 and a weighting of 5.25%. Keith A. Goldan also owns 133 shares of Fibrocell Science Inc (FCSC) as of August 11, 2015, with a value of $399 and a weighting of 0.06%.
Latest Holdings of Keith A. Goldan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2024-06-14 | 52,623 | 12.93 | 680,152 |
| OPTN | OptiNose Inc | 2021-09-16 | 90,193 | 0.42 | 37,683 |
| FCSC | Fibrocell Science Inc | 2015-08-11 | 133 | 3.00 | 399 |
Holding Weightings of Keith A. Goldan
Keith A. Goldan Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith A. Goldan has made a total of 2 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the acquisition of 1,250 shares on June 14, 2024, which cost Keith A. Goldan around $25,038.
According to the SEC Form 4 filings, Keith A. Goldan has made a total of 4 transactions in OptiNose Inc (OPTN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in OptiNose Inc is the sale of 578 shares on September 16, 2021, which brought Keith A. Goldan around $1,613.
According to the SEC Form 4 filings, Keith A. Goldan has made a total of 0 transactions in Fibrocell Science Inc (FCSC) over the past 5 years. The most-recent trade in Fibrocell Science Inc is the acquisition of 133 shares on August 11, 2015, which cost Keith A. Goldan around $12,660.
Insider Trading History of Keith A. Goldan
- 1
Keith A. Goldan Trading Performance
GuruFocus tracks the stock performance after each of Keith A. Goldan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith A. Goldan is -5.81%. GuruFocus also compares Keith A. Goldan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith A. Goldan within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith A. Goldan's insider trading performs compared to the benchmark.
Performance of Keith A. Goldan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.16 | | | | | |
| Relative Return to S&P 500(%) | 1.65 | | | | | |
Keith A. Goldan Ownership Network
Keith A. Goldan Owned Company Details
What does OptiNose Inc do?
Who are the key executives at OptiNose Inc?
Keith A. Goldan is the Chief Financial Officer of OptiNose Inc. Other key executives at OptiNose Inc include Chief Legal Officer & Corp Sec Marino Michael F Iii , President & COO Ramy A Mahmoud , and Chief Accounting Officer Anthony J Krick .
OptiNose Inc (OPTN) Insider Trades Summary
Over the past 18 months, Keith A. Goldan made no insider transaction in OptiNose Inc (OPTN). Other recent insider transactions involving OptiNose Inc (OPTN) include a net sale of 234,178 shares made by Ramy A Mahmoud , a net sale of 86,952 shares made by Marino Michael F Iii , and a net sale of 9,814 shares made by Anthony J Krick .
In summary, during the past 3 months, insiders sold 7,664 shares of OptiNose Inc (OPTN) in total and bought 0 shares, with a net sale of 7,664 shares. During the past 18 months, 330,944 shares of OptiNose Inc (OPTN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 330,944 shares.
OptiNose Inc (OPTN)'s detailed insider trading history can be found in Insider Trading Tracker table.
OptiNose Inc Insider Transactions
Keith A. Goldan Mailing Address
Above is the net worth, insider trading, and ownership report for Keith A. Goldan. You might contact Keith A. Goldan via mailing address: 227 Washington Street, Suite 200, Conshohocken Pa 19428.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
